🇬🇧❤️ WHAT AN INCREDIBLE WAY TO END AN EXTRAORDINARY WEEK IN LONDON!
Today, Braelyn received her 5th DCVax treatment with the wonderful Professor Keyoumars Ashkan at King’s College Hospital!
Prof. Ashkan was absolutely thrilled about the extraordinary week Braelyn has had in London. And apparently, word travels FAST! He already knew that Braelyn’s story had been shared in the House of Commons during Prime Minister’s Questions! 🇬🇧
But my favorite moment came when I mentioned Braelyn’s latest MRI, which showed NO EVIDENCE OF DISEASE. I had mailed him a hard copy and wanted to make sure he’d received it.
His response?
“I’VE SEEN IT! THE ENTIRE UK HAS SEEN IT!” 😂❤️
I just LOVE this man!
We had sent him and his wonderful assistant our “Because Gray Matter Matters” t-shirts after our last visit, but looking at these pictures, I think I may have seriously overestimated Prof. Ashkan’s shirt size! 😂
This brilliant, compassionate neurosurgeon has played such an important role in helping Braelyn access DCVax-L, and we will forever be grateful for his dedication to patients battling brain cancer.
From the halls of Parliament to another precious dose of Braelyn’s personalized cancer vaccine, what an unforgettable week!
Thank you, Professor Ashkan, for everything you do for Braelyn and so many other patients. You are truly extraordinary! ❤️🙏
#DCVaxForBrarlyn #BrainCancer #BraelynsFight
#DCvax
What an absolute honor to have been invited to sit in the Speaker’s VIP box. A huge Thank You to Sharon Hodgson, Labour MP for highlighting this very important issue affecting so many people in both of our countries, and beyond. We are grateful for the warm reception and the support of our “cousins” on the other side of the pond!
#DcVaxForBraelyn
@DrOzCMS
Can you hear the drum beat getting louder? We knew all along the potential of harnessing your own god given immune system. It was always about getting it to be cost efficient and to be mass produced. Join in the chorus, yell it from the roof top, beat the drums louder #NWBO
🇺🇸❤️ BIG NEWS & A LITTLE EXTRA HOPE! 🙏
We’re headed back to London for Braelyn’s next DCVax treatment, but this trip feels different!
This past week, I had the incredible opportunity to speak personally with @DrOz!
He’s been discussing Braelyn’s case with the FDA, and we’re exploring possible pathways to bring her ongoing DCVax treatments HOME to America!
Could Braelyn’s next treatment in MARCH actually happen right here in the USA?! 🇺🇸
Nothing is finalized, but some very important doors may be opening!
Please watch, share, and keep praying! ❤️🙏
#DCvaxForBraelyn
#BraelynsFight
@DrOzCMS
Yesterday, I had the privilege of attending the FDA’s Rare Disease Framework Initiative public meeting.
I had brain surgery for recurrent Glioblastoma (GBM) just a few weeks ago, but I flew to Maryland for this meeting because this new framework has the potential to change the future of GBM.
I’ve fought this disease for 4.5 years, using every tool available. But my best chance now, at recurrence, is a treatment that is currently only accessible in the UK, a personalized cancer vaccine called DCVaxL.
I made sure to freeze my tumor tissue specifically so I could have a chance at getting this vaccine. I should find out within the next week or two whether my tissue sample is adequate for vaccine manufacturing. More details to come.
@HollensbeAmanda@LoriMills4CA42@andrewcaravello@intrstedobservr
Said it before, say it again, #NWBO manufacturing... it is a massive key to buyout, finance guy, saudi, these are moves to leverage for a bigger buyout so they do not get low-balled.
🚨🇺🇸 BRAELYN’S STORY JUST MADE FOX BUSINESS! 🇺🇸🚨
What an incredible moment for our family!
Today on Varney & Co., Stuart Varney brought up Steve Moore’s recent Rasmussen Reports article about Braelyn and the barriers seriously ill Americans face in accessing promising experimental treatments!
Steve shared Braelyn’s story and called out the FDA, saying it’s CRUEL to withhold promising investigational treatments from desperately ill patients.
Varney agreed, arguing that patients facing terminal illnesses should have the freedom to accept the risks of experimental treatments without liability concerns preventing companies from providing them.
Then Steve asked a powerful question:
“Whatever happened to my body, my choice?”
He also pointed out that President Trump supports Right to Try, yet significant barriers remain between patients and the treatments they desperately need.
THIS is the conversation we’ve been fighting to bring into the national spotlight!
Our 19-year-old daughter is attending college, and her latest MRI shows no evidence of cancer recurrence. Yet we still have to travel to ENGLAND for her ongoing DCVax-L treatments—developed right here in AMERICA!
We are so incredibly grateful to Steve Moore and Stuart Varney for bringing attention to Braelyn’s story and, more importantly, to the countless patients who deserve a fighting chance.
Patients facing life-threatening illnesses shouldn’t have to fight their own government for the opportunity to fight for their lives.
PLEASE WATCH AND SHARE! ❤️🙏
@realDonaldTrump@DrOzCMS@SecKennedy
#DCVaxForBraelyn #RightToTry #DCVax
#BraelynsFight
$NWBO
🇺🇸❤️ WE MET PRESIDENT TRUMP TONIGHT! ❤️🇺🇸
What an extraordinary evening for our family!
Tonight, Braelyn, Ben, and I had the incredible opportunity to meet President Trump at the rally in Pendleton, South Carolina!
We had only about 20–30 seconds with him, and I knew I needed to make every second count.
I introduced him to Braelyn and thanked him for telling Dr. Oz about her brain cancer story.
I explained that Braelyn had been diagnosed with glioblastoma, the deadliest type of brain tumor, but that today she is CANCER-FREE after receiving DCVax-L, a personalized cancer vaccine developed right here in America!
Yet we must travel all the way to England for her ongoing treatments because we cannot access it here in the United States.
Then something pretty cool happened!
President Trump turned to one of his staffers and instructed them to get me in touch with Dr. Oz!
I also expressed my hope that we could connect with Secretary Kennedy.
As our brief time together came to an end, I made one final appeal:
“Please help bring this American-made treatment back home to America.”
President Trump was incredibly gracious to our family and very kind to Braelyn. We are so grateful for the opportunity to speak with him!
Earlier in the evening, I was also able to give a member of his staff a detailed packet about Braelyn’s journey, DCVax-L, and the obstacles American patients face in accessing promising investigational treatments.
Now we are praying that the connection with Dr. Oz comes through!
Three years ago, Braelyn was given just months to live. Today, she’s 19, attending college, and her latest MRI shows NO EVIDENCE OF DISEASE RECURRENCE!
Tonight, we had the opportunity to bring her story directly to the President of the United States. ❤️
My prayer is that this opens the door to a much bigger conversation—one that could change the future for countless American cancer patients.
📸 We were not permitted to bring our phones into the private meeting with President Trump, so we couldn’t take our own pictures with him. His staff took an official photograph of us together, which we’re told will be emailed to us. I can’t wait to share it! In the meantime, here are some pictures from our unforgettable evening.
Thank you to EVERYONE who helped make tonight possible and to all of you who continue to share Braelyn’s story. You helped us get this far, and we’re not stopping now! ❤️🙏
@realDonaldTrump@DrOzCMS@WhiteHouse
#DCVaxForBraelyn #DCVax
Personally I use the market manipulation to my advantage, cheap shares. My thesis is #NWBO will eventually sell itself to big pharmaceutical, and it won’t be for less than 14 cents.
@SouthernDrive21 Great news from the NHS mid-afternoon. Volume goes up and with minutes left in the trading day the price goes from .157 down to .148 ????? BUT! there's no manipulation ! Yea right... there's no algorithm! Yea right! The MM's can KMA. Where is Judge Stein?
#dcvax $nwbo #GBMG
WHO assigned Murcidencel with temporary 5th-level ATC code, Deadline for objection has passed, this signifies that a 'novel therapy is transitioning from a clinical trial concept into a formally recognized global drug entity.'
https://t.co/v1lc5LPj1Z
The TAM is not just rGBM or GBM, it’s cold tumors, it is all solid tumors. Keytruda and Opdivo do poorly against cold tumors. Now imagine if you can open the gate(s) for Big Pharma, imagine how desirable you become. #NWBO
Glioblastoma has historically been a dead end for PD-1 inhibitors because the tumor microenvironment is "cold" (lacking T cells). This trial provides the mechanistic proof that a dendritic cell vaccine can turn the tumor "hot," allowing Keytruda to work. Merck is 🍆💦 right now
Glioblastoma has historically been a dead end for PD-1 inhibitors because the tumor microenvironment is "cold" (lacking T cells). This trial provides the mechanistic proof that a dendritic cell vaccine can turn the tumor "hot," allowing Keytruda to work. Merck is 🍆💦 right now